Target intelligence / Profile preview

BRO1 domain-containing protein BROX (BROX)

Target
BROX
Molecular classification
Other (Accessory ESCRT machinery protein; contains a Bro1 domain), Structural protein associated with endosomal sorting complexes required for transport (ESCRT)
01

Overview

BRO1 domain-containing protein BROX (BROX) is an accessory factor in the ESCRT (endosomal sorting complex required for transport) machinery, involved in membrane remodeling, protein sorting, and nuclear envelope reassembly. The protein contains a single Bro1 domain and a C-terminal CAAX motif, which is farnesylated to enable membrane association. BROX binds the ESCRT-III subunit CHMP4, facilitating multivesicular body formation and proper endosomal cargo trafficking, including the regulation of proteins such as EGFR. Mutations in BROX are implicated in familial non-medullary thyroid cancer, highlighting a role in maintaining cellular homeostasis. BROX is upregulated by SGK1.1 and coordinates vesicular traffic with cell survival signaling, but it is dispensable for some ESCRT-associated viral events (e.g., HSV-1 budding). Structurally, BROX forms a curved domain similar to the yeast Bro1 and human ALIX proteins, with distinct features in its C-terminus relevant for membrane association and functional specificity. No drugs or clinical biomarkers are currently associated with BROX, and its status is primarily that of a cellular sorting accessory rather than a direct therapeutic target.

Other names
BROXBRO1 domain and CAAX motif containingBROFTIC1orf58FLJ32421BRO1 domain-containing protein BROXBRO1 domain-containing proteinBRO1 domain- and CAAX motif-containing proteinC1ORF58BROX_HUMAN
02

Mechanism of action

Not applicable. BROX is not currently a drug target

03

Biological functions

Endosomal sorting of cargo proteinsMultivesicular body (MVB) formationMitotic nuclear membrane reassemblySubcellular membrane targeting via farnesylation at CAAX motifIntracellular vesicular trafficCell survival pathway modulation
04

Disease associations

Cancer (implicated in familial non-medullary thyroid cancer due to loss-of-function mutations)Cellular homeostasis disruptionsOther (no proven roles in infection/viral budding)
05

Safety considerations

None described in literature; no known direct therapeutic targeting or toxicities
06

Interacting drugs

None currently known
07

Biomarkers

None currently validated for patient selection or efficacy monitoring

Beyond the preview

Go deeper on BRO1 domain-containing protein BROX (BROX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BRO1 domain-containing protein BROX (BROX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call